FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088694013> ?p ?o ?g. }

• W2088694013 abstract "Recent evidence suggests that the prostate cancer (PCa)-specific up-regulation of certain genes such as AMACR, EZH2, PSGR, PSMA and TRPM8 could be associated with an aberrant expression of non-coding microRNAs (miRNA). In silico analyses were used to search for miRNAs being putative regulators of PCa-associated genes. The expression of nine selected miRNAs (hsa-miR-101, -138, -186, -224, -26a, -26b, -374a, -410, -660) as well as of the aforementioned PCa-associated genes was analyzed by quantitative PCR using 50 malignant (Tu) and matched non-malignant (Tf) tissue samples from prostatectomy specimens as well as 30 samples from patients with benign prostatic hyperplasia (BPH). Then, correlations between paired miRNA and target gene expression levels were analyzed. Furthermore, the effect of exogenously administered miR-26a on selected target genes was determined by quantitative PCR and Western Blot in various PCa cell lines. A luciferase reporter assay was used for target validation. The expression of all selected miRNAs was decreased in PCa tissue samples compared to either control group (Tu vs Tf: -1.35 to -5.61-fold; Tu vs BPH: -1.17 to -5.49-fold). The down-regulation of most miRNAs inversely correlated with an up-regulation of their putative target genes with Spearman correlation coefficients ranging from -0.107 to -0.551. MiR-186 showed a significantly diminished expression in patients with non-organ confined PCa and initial metastases. Furthermore, over-expression of miR-26a reduced the mRNA and protein expression of its potential target gene AMACR in vitro. Using the luciferase reporter assay AMACR was validated as new target for miR-26a. The findings of this study indicate that the expression of specific miRNAs is decreased in PCa and inversely correlates with the up-regulation of their putative target genes. Consequently, miRNAs could contribute to oncogenesis and progression of PCa via an altered miRNA-target gene-interaction." @default.
• W2088694013 created "2016-06-24" @default.
• W2088694013 creator A5000162865 @default.
• W2088694013 creator A5002773830 @default.
• W2088694013 creator A5006860769 @default.
• W2088694013 creator A5026100807 @default.
• W2088694013 creator A5039751847 @default.
• W2088694013 creator A5065289402 @default.
• W2088694013 creator A5075981357 @default.
• W2088694013 creator A5090964318 @default.
• W2088694013 date "2014-02-11" @default.
• W2088694013 modified "2023-09-25" @default.
• W2088694013 title "Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs" @default.
• W2088694013 cites W1487984827 @default.
• W2088694013 cites W1540803423 @default.
• W2088694013 cites W1607591410 @default.
• W2088694013 cites W1648301895 @default.
• W2088694013 cites W1872235201 @default.
• W2088694013 cites W1963691340 @default.
• W2088694013 cites W1966056172 @default.
• W2088694013 cites W1983428971 @default.
• W2088694013 cites W1985997104 @default.
• W2088694013 cites W1993308240 @default.
• W2088694013 cites W1996487270 @default.
• W2088694013 cites W2002995168 @default.
• W2088694013 cites W2006720586 @default.
• W2088694013 cites W2012757292 @default.
• W2088694013 cites W2026258444 @default.
• W2088694013 cites W2034608727 @default.
• W2088694013 cites W2040182688 @default.
• W2088694013 cites W2041983200 @default.
• W2088694013 cites W2043780904 @default.
• W2088694013 cites W2048099871 @default.
• W2088694013 cites W2053554578 @default.
• W2088694013 cites W2061033976 @default.
• W2088694013 cites W2067419055 @default.
• W2088694013 cites W2079479637 @default.
• W2088694013 cites W2089531185 @default.
• W2088694013 cites W2089874345 @default.
• W2088694013 cites W2093557716 @default.
• W2088694013 cites W2100543217 @default.
• W2088694013 cites W2106787323 @default.
• W2088694013 cites W2115094397 @default.
• W2088694013 cites W2116205673 @default.
• W2088694013 cites W2123985787 @default.
• W2088694013 cites W2130979840 @default.
• W2088694013 cites W2133312453 @default.
• W2088694013 cites W2135810600 @default.
• W2088694013 cites W2148630375 @default.
• W2088694013 cites W2149848115 @default.
• W2088694013 cites W2150728173 @default.
• W2088694013 cites W2155979487 @default.
• W2088694013 cites W2160737079 @default.
• W2088694013 cites W2164687768 @default.
• W2088694013 cites W2167203269 @default.
• W2088694013 doi "https://doi.org/10.1186/1471-2407-14-82" @default.
• W2088694013 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3923006" @default.
• W2088694013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24517338" @default.
• W2088694013 hasPublicationYear "2014" @default.
• W2088694013 type Work @default.
• W2088694013 sameAs 2088694013 @default.
• W2088694013 citedByCount "49" @default.
• W2088694013 countsByYear W20886940132014 @default.
• W2088694013 countsByYear W20886940132015 @default.
• W2088694013 countsByYear W20886940132016 @default.
• W2088694013 countsByYear W20886940132017 @default.
• W2088694013 countsByYear W20886940132018 @default.
• W2088694013 countsByYear W20886940132019 @default.
• W2088694013 countsByYear W20886940132020 @default.
• W2088694013 countsByYear W20886940132021 @default.
• W2088694013 countsByYear W20886940132022 @default.
• W2088694013 countsByYear W20886940132023 @default.
• W2088694013 crossrefType "journal-article" @default.
• W2088694013 hasAuthorship W2088694013A5000162865 @default.
• W2088694013 hasAuthorship W2088694013A5002773830 @default.
• W2088694013 hasAuthorship W2088694013A5006860769 @default.
• W2088694013 hasAuthorship W2088694013A5026100807 @default.
• W2088694013 hasAuthorship W2088694013A5039751847 @default.
• W2088694013 hasAuthorship W2088694013A5065289402 @default.
• W2088694013 hasAuthorship W2088694013A5075981357 @default.
• W2088694013 hasAuthorship W2088694013A5090964318 @default.
• W2088694013 hasBestOaLocation W20886940131 @default.
• W2088694013 hasConcept C104317684 @default.
• W2088694013 hasConcept C111335760 @default.
• W2088694013 hasConcept C121608353 @default.
• W2088694013 hasConcept C145059251 @default.
• W2088694013 hasConcept C150194340 @default.
• W2088694013 hasConcept C153911025 @default.
• W2088694013 hasConcept C165864922 @default.
• W2088694013 hasConcept C2775905019 @default.
• W2088694013 hasConcept C2776235491 @default.
• W2088694013 hasConcept C2780192828 @default.
• W2088694013 hasConcept C502942594 @default.
• W2088694013 hasConcept C54009773 @default.
• W2088694013 hasConcept C54355233 @default.
• W2088694013 hasConcept C86803240 @default.
• W2088694013 hasConceptScore W2088694013C104317684 @default.
• W2088694013 hasConceptScore W2088694013C111335760 @default.
• W2088694013 hasConceptScore W2088694013C121608353 @default.
• W2088694013 hasConceptScore W2088694013C145059251 @default.

• next